Search Within

Antonio Marcilio Padula Omuro

  1. "Survivorship Research"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (10)
Groups
  1. Survivorship Research (22)
  2. Department of Medicine (18)
  3. Tow Center for Developmental Oncology (TCDO) (18)
  4. Center for Hematologic Malignancies (14)
  5. Hematologic Malignancies, Division of (14)
  6. Bone Marrow Transplant (11)

More Groups

People
  1. Lisa De Angelis (16)
  2. Craig Sauter (11)
  3. Matthew Matasar (11)
  4. Craig Moskowitz (10)
  5. Lauren Abrey (9)
  6. Thomas Kaley (8)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2017 (4)
  4. 2016 (1)
  5. 2015 (4)
  6. 2013 (3)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Neuro-Oncology (4)
  3. Blood (3)
  4. Biology of Blood and Marrow Transplantation (2)
  5. Annals of Clinical and Translational Neurology (1)
  6. Archives of Neurology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Oxford University Press (4)
  3. American Society of Hematology (3)
  4. Elsevier Inc. (2)
  5. Wiley Blackwell (2)
  6. American Medical Association (1)

More Publishers

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
    Journal Article

    Kaley, T. J.; Panageas, K. S.; Pentsova, E. I.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I.; DeAngelis, L. M.; Abrey, L. E.; Holland, E. C.; Omuro, A.; more...
    Annals of Clinical and Translational Neurology (2020)

    Fulltext@MSK | Save
  • Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation
    Journal Article

    Correa, D. D.; Braun, E.; Kryza-Lacombe, M.; Ho, K. W.; Reiner, A. S.; Panageas, K. S.; Yahalom, J.; Sauter, C. S.; Abrey, L. E.; DeAngelis, L. M.; more...
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • OncoKB: A precision oncology knowledge base
    Journal Article

    Chakravarty, D.; Gao, J.; Phillips, S.; Kundra, R.; Zhang, H.; Wang, J.; Rudolph, J. E.; Yaeger, R.; Soumerai, T.; Nissan, M. H.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
    Journal Article

    Thomas, A. A.; Abrey, L. E.; Terziev, R.; Raizer, J.; Martinez, N. L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C. S.; Moskowitz, C.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Toxicities and outcomes for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically (PK) directed busulfan in combination with thiotepa & cyclophosphamide (TBC) conditioning with HDT-ASCT in patients with primary & secondary CNS lymphoma
    Meeting Abstract

    Bhatt, V.; Scordo, M.; Hsu, M.; Omuro, A. M.; DeAngelis, L.; Lin, A.; Matasar, M. J.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
    Journal Article

    Welch, M. R.; Sauter, C. S.; Matasar, M. J.; Faivre, G.; Weaver, S. A.; Moskowitz, C. H.; Omuro, A. M.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save